StockNews.AI
AXDX
StockNews.AI
103 days

Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets

1. AXDX filed for Chapter 11 bankruptcy, seeking asset sales. 2. The company has secured $12.5 million in DIP financing. 3. Indaba Capital management offers a stalking horse bid of $36.9 million. 4. Sale process will involve court oversight and potential competitive bids. 5. The company aims to maintain normal operations during restructuring.

Bankruptcy
-67.41%Current Return
VS
+0.62%S&P 500
$0.466105/08 09:10 AM EDTEvent Start
$0.151905/09 03:51 PM EDTLatest Updated
6m saved
Insight
Article

FAQ

Why Very Bearish?

AXDX's Chapter 11 filing indicates severe financial distress, often leading to declining stock prices. Historical cases like Toys 'R' Us faced significant market devaluation post-bankruptcy filings.

How important is it?

The news directly relates to AXDX's financial stability and operation viability, crucial for investor sentiment and trading decisions.

Why Short Term?

The immediate market reaction to bankruptcy filings tends to be negative, reflecting in stock prices shortly after announcements, as seen with recent bankruptcies in various sectors.

Related Companies

INDOOCGNPTCXRGCCRNT
, /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) ("Accelerate" or the Company") today announced that it has voluntarily initiated a Chapter 11 restructuring proceeding in the United States Bankruptcy Court for the District of Delaware ("Bankruptcy Court") and will seek to sell its assets through a court supervised sale process. Accelerate has filed various "first day" motions with the Bankruptcy Court requesting customary relief that will enable the Company to transition into Chapter 11 without material disruption to their ordinary course operations, including seeking authority to obtain debtor-in-possession ("DIP") financing and pay employee wages and benefits. DIP Financing To provide necessary funding during the Chapter 11 proceeding, Accelerate has received a commitment of up to $12.5 million in a multi-draw DIP financing facility. Upon approval by the Bankruptcy Court, the DIP financing is expected to provide Accelerate with the necessary liquidity to operate in the normal course and meet obligations to its employees, vendors and customers throughout the Chapter 11 proceeding while executing on the sale process. Sale Process Prior to the Chapter 11 filing, and subject to Bankruptcy Court approval, the Company agreed to terms with Indaba Capital Management ("Indaba") – a majority holder of the Company's prepetition secured notes -- to acquire substantially all the assets of the Company.  The purchase price of Indaba's "stalking horse" bid includes (i) a credit bid of $36.9 million of Indaba's existing secured notes and DIP financing facility, (ii) certain assumed liabilities, and (iii) excluded cash sufficient to wind-down the Company following sale closing.  The transaction is part of a sale process under Section 363 of the Bankruptcy Code that will be subject to compliance with agreed upon and Bankruptcy Court-approved bidding procedures allowing for the submission of higher or otherwise better offers, and other agreed-upon conditions. In addition, the transaction is subject to customary closing conditions. In accordance with the sale process, notice of the proposed sale to Indaba will be given to third parties and competing bids will be solicited. The Company will manage the bidding process and evaluate any bids received, in consultation with its advisors and as overseen by the Bankruptcy Court.  In the event additional qualified bids are received, the Company will conduct an auction for the sale of its assets.  If no other qualified bids are received, Indaba will be deemed the successful bidder. Accelerate is represented by Fried, Frank, Harris, Shriver & Jacobson LLP as counsel, Solic Capital as financial advisor and Perella Weinberg Partners L.P. as restructuring investment banker. Additional information about the Chapter 11 case, including access to Bankruptcy Court documents, is available online at https://cases.stretto.com/AccelerateDiagnostics. SOURCE Accelerate Diagnostics, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News